Single-domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP-ribosylating toxin of Salmonella typhimurium

FASEB Journal

Volumn 25, Issue 2, 2011, Pages 526-534

  Alzogaray, Vanina ^a   Danquah, Welbeck ^b   Aguirre, Andrés ^c   Urrutia, Mariela ^a   Berguer, Paula ^a   García Véscovi, Eleonora ^c   Haag, Friedrich ^b   Koch Nolte, Friedrich ^b   Goldbaum, Fernando A ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Enzyme inhibition; Intrabodies; VHH

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; CHIMERIC ANTIBODY; SPVB; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; VERO CELL; WILD TYPE;

ACTINS; ADP RIBOSE TRANSFERASES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; CAMELIDS, NEW WORLD; CELL LINE; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; GENE EXPRESSION REGULATION; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SALMONELLA TYPHIMURIUM; VERO CELLS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); LAMA (MAMMAL); SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 79551645748     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-162958     Document Type: Article

References (66)

1. Lindgren, S. W., Stojiljkovic, I., and Heffron, F. (1996) Macrophage killing is an essential virulence mechanism of Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 93, 4197-4201
2. Fierer, J., and Guiney, D. G. (2001) Diverse virulence traits underlying different clinical outcomes of Salmonella infection. J. Clin. Invest. 107, 775-780
3. Fields, P. I., Swanson, R. V., Haidaris, C. G., and Heffron, F. (1986) Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl. Acad. Sci. U. S. A. 83, 5189-5193
4. Vassiloyanakopoulos, A. P., Okamoto, S., and Fierer, J. (1998) The crucial role of polymorphonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice. Proc. Natl. Acad. Sci. U. S. A. 95, 7676-7681
5. Worley, M. J., Nieman, G. S., Geddes, K., and Heffron, F. (2006) Salmonella typhimurium disseminates within its host by manipulating the motility of infected cells. Proc. Natl. Acad. Sci. U. S. A. 103, 17915-17920
6. Fierer, J., Krause, M., Tauxe, R., and Guiney, D. (1992) Salmonella typhimurium bacteremia: association with the virulence plasmid. J. Infect. Dis. 166, 639-642
7. Libby, S. J., Lesnick, M., Hasegawa, P., Weidenhamme, R. E., and Guiney, D. G. (2000) The Salmonella virulence plasmid spv genes are required for cytopathology in human monocyte-derived macrophages. Cell Micro. 2, 49-58
8. Matsui, H., Bacot, C. M., Garlington, W. A., Doyle, T. J., Roberts, S., and Gulig, P. A. (2001) Virulence plasmid-borne spvB and spvC genes can replace the 90-kilobase plasmid in conferring virulence to Salmonella enterica serovar Typhimurium in subcutaneously inoculated mice. J. Bacteriol. 183, 4652-4658
9. Browne, S. H., Lesnick, M. L., and Guiney, D. G. (2002) Genetic requirements for Salmonella-induced cytopathology in human monocyte-derived macrophages. Infect. Immun. 70, 7126-7135
10. Lesnick, M. L., Reiner, N. E., Fierer, J., and Guiney, D. G. (2001) The Salmonella spvB virulence gene encodes an enzyme that ADP-ribosylates actin and destabilizes the cytoskeleton of eukaryotic cells. Mol. Microbiol. 39, 1464-1470
11. Otto, H., Tezcan-Merdol, D., Girisch, R., Haag, F., Rhen, M., and Koch-Nolte, F. (2000) The spvB gene-product of the Salmonella enterica virulence plasmid is a mono(ADP-ribosyl) transferase. Mol. Microbiol. 37, 1106-1115
12. Tezcan-Merdol, D., Nyman, T., Lindberg, U., Haag, F., Koch- Nolte, F., and Rhen, M. (2001) Actin is ADP-ribosylated by the Salmonella enterica virulence-associated protein SpvB. Mol. Microbiol. 39, 606-619
13. Browne, S. H., Hasegawa, P., Okamoto, S., Fierer, J., and Guiney, D. G. (2008) Identification of Salmonella SPI-2 secretion system components required for SpvB-mediated cytotoxicity in macrophages and virulence in mice. FEMS Immunol. Med. Microbiol. 52, 194-201
14. Margarit, S. M., Davidson, W., Frego, L., and Stebbins, C. E. (2006) A steric antagonism of actin polymerization by a Salmonella virulence protein. Structure 14, 1219-1229
15. Kurita, A., Gotoh, H., Eguchi, M., Okada, N., Matsuura, S., Matsui, H., Danbara, H., and Kikuchi, Y. (2003) Intracellular expression of the Salmonella plasmid virulence protein, SpvB, causes apoptotic cell death in eukaryotic cells. Microb. Pathog. 35, 43-48
16. Koch-Nolte, F., Kernstock, S., Mueller-Dieckmann, C., Weiss, M. S., and Haag, F. (2008) Mammalian ADP-ribosyltransferases and ADP-ribosylhydrolases. Front. Biosci. 13, 6716-6729
17. Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hamers, C., Songa, E. B., Bendahman, N., and Hamers, R. (1993) Naturally occurring antibodies devoid of light chains. Nature 363, 446-448
18. Muyldermans, S., Cambillau, C., and Wyns, L. (2001) Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem. Sci. 26, 230-235
19. Harmsen, M. M., and De Haard, H. J. (2007) Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 77, 13-22
20. Wesolowski, J., Alzogaray, V., Reyelt, J., Unger, M., Juarez, K., Urrutia, M., Cauerhff, A., Danquah, W., Rissiek, B., Scheuplein, F., Schwarz, N., Adriouch, S., Boyer, O., Seman, M., Licea, A., Serreze, D. V., Goldbaum, F. A., Haag, F., and Koch-Nolte, F. (2009) Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med. Microbiol. Immunol. 198, 157-174
21. Conrath, E. K., Lauwereys, M., Wyns, L., and Muyldermans, S. (2001) Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J. Biol. Chem. 276, 7346-7350
22. Dumoulin, M., Conrath, K., Van Meirhaeghe, A., Meersman, F., Heremans, K., Frenken, L. G., Muyldermans, S., Wyns, L., and Matagne, A. (2002) Single-domain antibody fragments with high conformational stability. Protein Sci. 11, 500-515
23. Roovers, R., Laeremans, T., Huang, L., De Taeye, S., Verkleij, A., Revets, H., de Haard, H. J., and van Bergen en Henegouwen, P. M. (2007) Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR nanobodies. Cancer Immunol Immunother 56, 303-317
24. Tijink, B. M., Laeremans, T., Budde, M., Stigter-van Walsum, M., Dreier, T., de Haard, H. J., Leemans, C. R., and van Dongen, G. A. (2008) Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular nanobody technology. Mol. Cancer Ther. 7, 2288-2297
25. Desmyter, A., Transue, T. R., Ghahroudi, M. A., Thi, M. H., Poortmans, F., Hamers, R., Muyldermans, S., and Wyns, L. (1996) Crystal structure of a camel single-domain VH anti-body fragment in complex with lysozyme. Nat. Struct. Biol. 3, 803-811
26. De Genst, E., Silence, K., Decanniere, K., Conrath, K., Loris, R., Kinne, J., Muyldermans, S., and Wyns, L. (2006) Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc. Natl. Acad. Sci. U. S. A. 103, 4586-4591
27. Lauwereys, M., Arbabi Ghahroudi, M., Desmyter, A., Kinne, J., Hölzer, W., De Genst, E., Wyns, L., and Muyldermans, S. (1998) Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J. 17, 3512-3520
28. Muyldermans, S., Baral, T. N., Retamozzo, V. C., De Baetselier, P., De Genst, E., Kinne, J., Leonhardt, H., Magez, S., Nguyen, V. K., Revets, H., Rothbauer, U., Stijlemans, B., Tillib, S., Wernery, U., Wyns, L., Hassanzadeh-Ghassabeh, G., and Saerens, D. (2009) Camelid immunoglobulins and nanobody technology. Vet. Immunol. Immunopathol. 128, 178-183
29. Cortez-Retamozo, V., Backmann, N., Senter, P. D., Wernery, U., De Baetselier, P., Muyldermans, S., and Revets, H. (2004) Efficient cancer therapy with a nanobody-based conjugate. Cancer Res. 64, 2853-2857
30. Baral, T. N., Magez, S., Stijlemans, B., Conrath, K., Vanhollebeke, B., Pays, E., Muyldermans, S., and De Baetselier, P. (2006) Experimental therapy of African trypanosomiasis with a nano-body- conjugated human trypanolytic factor. Nat. Med. 12, 580-584
31. Coppieters, K., Dreier, T., Silence, K., De Haard, H., Lauwereys, M., Casteels, P., Beirnaert, E., Jonckheere, H., Van de Wiele, C., Staelens, L., Hostens, J., Revets, H., Remaut, E., Elewaut, D., and Rottiers, P. (2006) Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis. Arthritis Rheum. 54, 1856-1866
32. Koch-Nolte, F., Reyelt, J., Schössow, B., Schwarz, N., Scheuplein, F., Rothenburg, S., Haag, F., Alzogaray, V., Cauerhff, A., and Goldbaum, F. A. (2007) Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo. FASEB J. 21, 3490-3498
33. Dumoulin, M., Last, A. M., Desmyter, A., Decanniere, K., Canet, D., Larsson, G., Spencer, A., Archer, D. B., Sasse, J., Muyldermans, S., Wyns, L., Redfield, C., Matagne, A., Robinson, C. V., and Dobson, C. M. (2003) A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 424, 783-788
34. Habicht, G., Haupt, C., Friedrich, R. P., Hortschansky, P., Sachse, C., Meinhardt, J., Wieligmann, K., Gellermann, G. P., Brodhun, M., Götz, J., Halbhuber, K. J., Röcken, C., Horn, U., and Fändrich, M. (2007) Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc. Natl. Acad. Sci. U. S. A. 104, 19232-19237
35. Rothbauer, U., Zolghadr, K., Tillib, S., Nowak, D., Schermelleh, L., Gahl, A., Backmann, N., Conrath, K., Muyldermans, S., Cardoso, M. C., and Leonhardt, H. (2006) Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat. Methods 3, 887-889
36. Gueorguieva, D., Li, S., Walsh, N., Mukerji, A., Tanha, J., and Pandey, S. (2006) Identification of single-domain, Bax-specific intrabodies that confer resistance to mammalian cells against oxidative-stress-induced apoptosis. FASEB J. 20, 2636-2638
37. Chartier, A., Raz, V., Sterrenburg, E., Verrips, C. T., van der Maarel, S. M., and Simonelig, M. (2009) Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo. Hum. Mol. Genet. 18, 1849-1859
38. Paz, K., Brennan, L. A., Iacolina, M., Doody, J., Hadari, Y. R., and Zhu, Z. (2005) Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation. Mol. Cancer Ther. 4, 1801-1809
39. Jendreyko, N., Popkov, M., Rader, C., and Barbas, C. F., 3rd (2005) Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo. Proc. Natl. Acad. Sci. U. S. A. 102, 8293-8298
40. Lo, A. S., Zhu, Q., and Marasco, W. A. (2008) Intracellular antibodies (intrabodies) and their therapeutic potential. Handb. Exp. Pharmacol. 343-373
41. Aires da Silva, F., Santa-Marta, M., Freitas-Vieira, A., Mascarenhas, P., Barahona, I., Moniz-Pereira, J., Gabuzda, D., and Goncalves, J. (2004) Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity. J. Mol. Biol. 340, 525-542
42. Jobling, S. A., Jarman, C., Teh, M. M., Holmberg, N., Blake, C., and Verhoeyen, M. E. (2003) Immunomodulation of enzyme function in plants by single-domain antibody fragments. Nat. Biotechnol. 21, 77-80
43. Serruys, B., Van Houtte, F., Verbrugghe, P., Leroux-Roels, G., and Vanlandschoot, P. (2009) Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice. Hepatology 49, 39-49
44. Delanote, V., Vanloo, B., Catillon, M., Friederich, E., Vandekerckhove, J., and Gettemans, J. (2010) An alpaca single-domain antibody blocks filopodia formation by obstructing L-plastin-mediated F-actin bundling. FASEB J. 24, 105-118
45. Vercruysse, T., Pardon, E., Vanstreels, E., Steyaert, J., and Daelemans, D. (2010) An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 REV prevents viral production. J. Biol. Chem.
46. Aktories, K., and Barbieri, J. T. (2005) Bacterial cytotoxins: targeting eukaryotic switches. Nat. Rev. Microbiol. 3, 397-410
47. Collier, R. J. (2001) Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century. Toxicon 39, 1793-1803
48. Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R., Gerding, D. N., Nichol, G., Thomas, W. D., Jr., Leney, M., Sloan, S., Hay, C. A., and Ambrosino, D. M. Treatment with monoclonal antibodies against Clostridium difficile toxins. N. Engl. J. Med. 362, 197-205
49. Boersma, W. J., Bogaerts, W. J., Bianchi, A. T., and Claassen, E. (1992) Adjuvant properties of stable water-in-oil emulsions: evaluation of the experience with Specol. Res. Immunol. 143, 503-512
50. Zarebski, L. M., Urrutia, M., and Goldbaum, F. A. (2005) Llama single domain antibodies as a tool for molecular mimicry. J. Mol. Biol. 349, 814-824
51. Ratier, L., Urrutia, M., Paris, G., Zarebski, L., Frasch, A. C., and Goldbaum, F. A. (2008) Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies. PLoS ONE 3, e3524
52. Kouyama, T., and Mihashi, K. (1981) Fluorimetry study of N-(1-pyrenyl)iodoacetamide-labelled F-actin. Local structural change of actin protomer both on polymerization and on binding of heavy meromyosin. Eur. J. Biochem. 114, 33-38
53. Muyldermans, S. (2001) Single domain camel antibodies: current status. J. Biotechnol. 74, 277-302
54. Gotoh, H., Okada, N., Kim, Y. G., Shiraishi, K., Hirami, N., Haneda, T., Kurita, A., Kikuchi, Y., and Danbara, H. (2003) Extracellular secretion of the virulence plasmid-encoded ADP-ribosyltransferase SpvB in Salmonella. Microb. Pathog. 34, 227-238
55. Pust, S., Hochmann, H., Kaiser, E., von Figura, G., Heine, K., Aktories, K., and Barth, H. (2007) A cell-permeable fusion toxin as a tool to study the consequences of actin-ADP-ribosylation caused by the Salmonella enterica virulence factor SpvB in intact cells. J. Biol. Chem. 282, 10272-10282
56. Aktories, K., Barmann, M., Ohishi, I., Tsuyama, S., Jakobs, K. H., and Habermann, E. (1986) Botulinum C2 toxin ADP-ribosylates actin. Nature 322, 390-392
57. Barth, H., Blocker, D., Behlke, J., Bergsma-Schutter, W., Brisson, A., Benz, R., and Aktories, K. (2000) Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification. J. Biol. Chem. 275, 18704-18711
58. Cohen-Saidon, C., Nechushtan, H., Kahlon, S., Livni, N., Nissim, A., and Razin, E. (2003) A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival. Blood 102, 2506-2512
59. Avignolo, C., Bagnasco, L., Biasotti, B., Melchiori, A., Tomati, V., Bauer, I., Salis, A., Chiossone, L., Mingari, M. C., Orecchia, P., Carnemolla, B., Neri, D., Zardi, L., and Parodi, S. (2008) Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein. FASEB J. 22, 1237-1245
60. Granelli-Piperno, A., Pritsker, A., Pack, M., Shimeliovich, I., Arrighi, J. F., Park, C. G., Trumpfheller, C., Piguet, V., Moran, T. M., and Steinman, R. M. (2005) Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/ CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J. Immunol. 175, 4265-4273
61. Marquardt, A., Muyldermans, S., and Przybylski, M. (2006) A synthetic camel anti-lysozyme peptide antibody (peptibody) with flexible loop structure identified by high-resolution affinity mass spectrometry. Chemistry (Weinheim an der Bergstrasse, Germany) 12, 1915-1923
62. Deng, Q., and Barbieri, J. T. (2008) Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins. Annu. Rev. Microbiol. 62, 271-288
63. Engel, J., and Balachandran, P. (2009) Role of Pseudomonas aeruginosa type III effectors in disease. Curr. Opin. Microbiol. 12, 61-66
64. Henry, T., Couillault, C., Rockenfeller, P., Boucrot, E., Dumont, A., Schroeder, N., Hermant, A., Knodler, L. A., Lecine, P., Steele-Mortimer, O., Borg, J. P., Gorvel, J. P., and Meresse, S. (2006) The Salmonella effector protein PipB2 is a linker for kinesin-1. Proc. Natl. Acad. Sci. U. S. A. 103, 13497-13502
65. Hueck, C. J. (1998) Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62, 379-433
66. Galan, J. E., and Collmer, A. (1999) Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284, 1322-1328